Bioarctic AB (publ)
Market Cap (Aug-2026)
3.144 Billion USD
World Rank (Jan-05-2024)
5,245
Market Cap (Jan-05-2024)
2.290 Billion USD
World Rank (Jul-30-2023)
5,000
Market Cap (Jul-30-2023)
2.461 Billion USD
World Rank (Dec-25-2022)
4,970
Market Cap (Dec-25-2022)
2.293 Billion USD
World Rank (Jan-07-2022)
8,941
Market Cap (Jan-07-2022)
1.09 Billion USD
Annual Revenue in USD
2 Million USD
Annual Net Income in USD
-11 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
BioArctic AB (publ) is a Swedish research based biopharma company focusing on disease modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. The company annual revenue is 62.3 million SEK and total assets are 1,050 million SEK as on 2020. The headquarters is in Sweden.
Company Website